IMUX•benzinga•
Immunic Announced Presentation Of Data On Nuclear Receptor-Related 1 (Nurr1) Activator, Vidofludimus Aalcium (IMU-838), In Two Poster Presentations At The Americas Committee For Treatment And Research In Multiple Sclerosis Forum 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 26, 2025 by benzinga